Teva CEO on Staying Competitive in Generic Drug Market

Kåre Schultz, CEO at Teva Pharmaceutical, talks about the company's restructuring plans as well as his outlook for drug development. He says more than 90% of U.S. pharmaceuticals are generics and one out of ten drugs is produced by Teva. Host: Jason Kelly. Producer: Doni Holloway.

2356 232